Lindner Named Director of CSR Office
The Center for Scientific Review has named Dr. Mark Lindner as new director of its Office of Planning, Analysis and Evaluation. He has been working part-time in this office for the last 5½ years while serving as scientific review officer for several CSR study sections, including small business applications and, most recently, cognition and perception.
“I am very pleased that Mark will be stepping into this critical position,” said CSR director Dr. Richard Nakamura. “His scientific, analytic and statistical expertise is broad and deep. He also brings remarkable insight into current and needed research to evaluate and improve peer review.”
The Office of Planning, Analysis and Evaluation provides data, analysis and evaluations of the peer review of NIH grant applications for special projects, inquiries and advisory council activities.
Lindner received his Ph.D. in biopsychology from the University of Texas. After postdoctoral training, he spent 15 years managing and coordinating drug discovery research in industry at CytoTherapeutics in Lincoln, R.I.; Neurocrine Biosciences in San Diego; and Bristol-Myers Squibb in Wallingford, Conn. He also did consulting with McArthur and Associates GmbH, in Basel, Switzerland.
Lindner has published numerous papers that discuss how scientific research can be evaluated, conducted and managed to increase scientific productivity and the rate of progress. His interests range from the reductionist focus on molecular mechanisms to the psychology of the scientist and systemic and organizational factors that affect human judgment and decision-making.